ProfileGDS4718 / 1561037_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 42% 43% 44% 39% 44% 44% 42% 36% 41% 41% 33% 45% 53% 47% 41% 41% 42% 42% 39% 47% 44% 39% 42% 42% 50% 40% 47% 33% 48% 50% 43% 35% 42% 48% 48% 51% 40% 43% 45% 45% 51% 46% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0248841
GSM549102patient 115, normal, homogenized [OPG study]5.0955542
GSM549104patient 119, normal, homogenized [OPG study]5.1264943
GSM549108patient 138, normal, homogenized [OPG study]5.2331344
GSM549119patient 077, normal, homogenized [OPG study]4.9704539
GSM549133patient 032, cancer, homogenized [OPG study]5.1122544
GSM549139patient 042, cancer, homogenized [OPG study]5.1588944
GSM549099patient 107, normal, homogenized [OPG study]5.1249942
GSM549109patient 139, normal, homogenized [OPG study]4.831336
GSM549110patient 046, normal, homogenized [OPG study]5.0584841
GSM549114patient 063, normal, homogenized [OPG study]5.0008841
GSM549122patient 082, normal, homogenized [OPG study]4.6877733
GSM549134patient 033, cancer, homogenized [OPG study]5.2478745
GSM549136patient 036, cancer, homogenized [OPG study]5.6201453
GSM549140patient 044, cancer, homogenized [OPG study]5.2901547
GSM549111patient 047, normal, homogenized [OPG study]5.0408941
GSM549113patient 057, normal, homogenized [OPG study]4.9826941
GSM549132patient 031, cancer, homogenized [OPG study]5.0746242
GSM549137patient 038, cancer, homogenized [OPG study]5.0860442
GSM549142patient 047, cancer, homogenized [OPG study]5.0707639
GSM549100patient 110, normal, homogenized [OPG study]5.3617447
GSM549107patient 135, normal, homogenized [OPG study]5.1431344
GSM549115patient 068, normal, homogenized [OPG study]4.877339
GSM549116patient 072, normal, homogenized [OPG study]5.0621242
GSM549120patient 078, normal, homogenized [OPG study]5.0909942
GSM549131patient 030, cancer, homogenized [OPG study]5.4670650
GSM549118patient 074, normal, homogenized [OPG study]4.9772440
GSM549129patient 027, cancer, homogenized [OPG study]5.3697247
GSM549123patient 088, normal, homogenized [OPG study]4.6713633
GSM549124patient 006, cancer, homogenized [OPG study]5.4141348
GSM549126patient 015, cancer, homogenized [OPG study]5.4778450
GSM549128patient 025, cancer, homogenized [OPG study]5.1243943
GSM549103patient 117, normal, homogenized [OPG study]4.8192435
GSM549117patient 073, normal, homogenized [OPG study]5.0380242
GSM549138patient 041, cancer, homogenized [OPG study]5.3926648
GSM549141patient 045, cancer, homogenized [OPG study]5.3743348
GSM549130patient 028, cancer, homogenized [OPG study]5.5662251
GSM549101patient 111, normal, homogenized [OPG study]5.0425440
GSM549105patient 128, normal, homogenized [OPG study]5.1756943
GSM549106patient 134, normal, homogenized [OPG study]5.1661245
GSM549112patient 048, normal, homogenized [OPG study]5.2355145
GSM549125patient 011, cancer, homogenized [OPG study]5.586251
GSM549127patient 024, cancer, homogenized [OPG study]5.2764946
GSM549135patient 035, cancer, homogenized [OPG study]5.9018257